ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas (Q35741942)
scientific article published on April 2004
Language:
Current Data About ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas
(P31) (Q13442814)
(P248)
(P698) 15073862
(P813) Thursday, August 10, 2017

(P304) 1717-1723
(P248)
(P698) 15073862
(P813) Thursday, August 10, 2017

(P407) (Q1860)

(P433) 8
(P248)
(P698) 15073862
(P813) Thursday, August 10, 2017

(P478) 100
(P248)
(P698) 15073862
(P813) Thursday, August 10, 2017

(P577) Thursday, April 1, 2004
(P248)
(P698) 15073862
(P813) Thursday, August 10, 2017

(P921) (Q1475848)

(Q9397786)
(P887)

(P1433) (Q326041)
(P248)
(P698) 15073862
(P813) Thursday, August 10, 2017

(P1476) "ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas" (language: en)
(P248)
(P698) 15073862
(P813) Thursday, August 10, 2017

(P2093) Michael B Streiff
(P1545) 1
(P248)
(P698) 15073862
(P813) Thursday, August 10, 2017

Jodi Segal
(P1545) 2
(P248)
(P698) 15073862
(P813) Thursday, August 10, 2017

Stuart A Grossman
(P1545) 3
(P248)
(P698) 15073862
(P813) Thursday, August 10, 2017

Thomas S Kickler
(P1545) 4
(P248)
(P698) 15073862
(P813) Thursday, August 10, 2017

Edward G Weir
(P1545) 5
(P248)
(P698) 15073862
(P813) Thursday, August 10, 2017

(P2860) (Q48143338)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Sunday, January 21, 2018

(Q41033291)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q55489414)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q55483868)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q48590023)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q39341906)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q71167389)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q71951032)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q40522519)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q34748945)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q33991934)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q50856939)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q72414738)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q74197149)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q36585685)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q77357100)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q50534746)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q40522538)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

(Q34389365)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.20150
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published on April 2004

External Links
(P356) 10.1002/CNCR.20150
(P698) 15073862
(P5875) 227772091
(P8608) release_b7qqt63d6vcs7e4mbxh3mnwb6a